In-depth NMPA Regulatory Expertise: A Regulatory Moat Spanning "Compliance Market Access" to "Shared Accountability" 

Within the medical device sector, regulations serve not only as the threshold for product market access, but also the cornerstone and lifeline for sustainable corporate operation. Yikangshengyuan’s core competitive advantage stems from our profound understanding and forward-looking application of the Regulations on the Supervision and Administration of Medical Devices and its supporting regulatory documents, enabling us to build a solid regulatory moat within the highly specialized field of imported medical device Domestic Responsible Person services. 

We fully recognize that under current Chinese regulatory rules, overseas medical device manufacturers cannot independently fulfill statutory obligations within China. Therefore, appointing a Chinese legal entity as their Domestic Responsible Person (DRP) is a legal prerequisite for products to enter the Chinese market—and we fill this indispensable role as a statutory regulatory bridge. This is far more than a nominal proxy service; guided by thorough insight into the intent of regulatory provisions, we deliver in-depth full-lifecycle compliance protection covering pre-market access through post-market supervision for our clients.

1. Compliance Market Access Specialists for Registration & Filing

At the product market access stage, our core value lies in translating complex regulatory requirements into clear, actionable workflows for clients, ensuring smooth passage through NMPA review procedures.

Precise Document Conversion & Compliance Audit

We are more than mere translators of technical files—we act as regulatory interpreters. All foreign-language technical documentation from overseas manufacturers, including product technical requirements, clinical evaluation data, and risk analysis reports, must be accurately converted into Chinese submission files fully aligned with NMPA standards. Drawing on our intimate grasp of NMPA review logic, we guarantee the authenticity, completeness and compliance of every submitted document, eliminating review delays or rejection caused by substandard documentation from the source. 

Forward-Looking Quality System Guidance

We recognize that product compliance is rooted in robust manufacturing quality management systems. We provide targeted guidance to overseas manufacturers to align their ISO 13485 quality management systems not only with international standards, but also seamlessly with China’s domestic regulatory codes and criteria. This forward-looking advisory work establishes a solid compliance foundation prior to registration filings, avoiding massive rectification costs arising from system non-compliance later in the process.

Efficient Communication Hub & Process Accelerator 

As the statutorily designated communication channel between overseas manufacturers and NMPA, we submit registration applications on clients’ behalf and track review progress end-to-end. Leveraging extensive experience with review workflows and potential inquiries, we promptly and accurately relay official review comments, and assist overseas manufacturers in drafting professional, comprehensive supplementary data responses. This approach drastically shortens approval timelines, streamlines all regulatory communication, and safeguards successful product registration. 

2. Shared-Accountability Partners for Post-Market Supervision

Product registration and launch mark merely the starting point of a long-term compliance journey. As regulatory oversight continues to tighten, the role of the Domestic Responsible Person has evolved from a procedural agent into a strategic partner that shares legal accountability with overseas Marketing Authorization Holders (MAHs). We fully embrace this transformation, recognizing our critical role as a compliance firewall guaranteeing the safe, legal sale of clients’ products within China.

Embracing the New Regulatory Norm of Joint and Several Liability

Latest regulatory guidance explicitly stipulates that Domestic Responsible Persons bear joint and several liability alongside overseas MAHs. This means the DRP’s compliance capacity directly determines the viability of the product in the Chinese market. We treat this not merely as a statutory obligation, but as a core service principle. We fully acknowledge that our clients’ compliance risks represent our own operational bottom line. Accordingly, we prioritize risk prevention and control across all our operations, ensuring every procedure withstands the strictest regulatory scrutiny and fully protecting our clients’ long-term commercial interests. 

Establishing a Full-Lifecycle Post-Market Supervision System

We build and operate a complete, efficient post-market compliance framework for clients to sustain continuous regulatory adherence throughout the entire product lifecycle: 

• Vigilance & Pharmacovigilance System: We maintain standardized procedures for adverse event collection, scientific analysis and statutory reporting within China. We actively cooperate with regulatory authorities to conduct safety evaluations, minimizing all potential product risks. 

• Product Traceability & Recall Management: We support clients in constructing traceability systems compliant with Chinese regulations. In the event of quality defects or safety hazards, we act as the accountable party to promptly initiate and lawfully execute product recalls, maximizing protection for patient safety and corporate brand reputation.

• Change & Re-Registration Administration: Throughout the product lifecycle, we submit applications for registration amendments or filings for any adjustments to design, manufacturing processes or intended use. Prior to registration certificate expiry, we proactively plan and complete renewal registration to maintain uninterrupted legal operation.

Ensuring Stable Annual Compliance Operations

We rigorously fulfill all statutory duties as the Domestic Responsible Person, submitting comprehensive annual reports to local drug regulatory authorities on schedule, detailing domestic sales performance, post-market research and risk management status of all products. We also assist overseas manufacturers in completing annual internal audits of their quality management systems to sustain effective QMS operation. These standardized, proceduralized services underpin our commitment to shared accountability, delivering full-coverage, uninterrupted compliance for our clients’ products in the Chinese market.